No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Lindis Blood Care announces successful conclusion of blood salvage trial
The company has said that its Remove study investigating the company’s Catuvab device has seen its last patient successfully finish the trial.
Cell salvage: the tech at the cutting edge of blood management
In April 2019, Illinois-based Ecomed Solutions launched HEMAsavR, a blood management device that can be installed in operating theatres to collect a patient’s lost blood during surgery and return it to their body. Known as cell salvage, this technology could have a huge impact on the way surgeries are carried out, bypassing the cost and risk associated with allogeneic blood transfusion.
University of Strathclyde secures CDE grant to develop portable blood salvage device
The University of Strathclyde has secured Centre for Defence Enterprise (CDE) funding to develop and assess a novel blood salvage device to reduce loss of blood in severely injured personnel during war.
Penumbra sees 85.5% limb salvage rate in thrombectomy device trial
The multicenter trial of the company’s Indigo Aspiration system met its primary endpoint of safety and effectiveness, seeing a high rate of limb salvage following a mechanical thrombectomy.
TherOx commences SSO2 therapy device IDE study
US-based medical device company TherOx has commenced an investigational device exemption (IDE) pilot study of its new supersaturated oxygen (SSO2) therapy device.
The cutting edge of contact lens technology in the latest Medical Technology
In this issue: the most influential innovations in the contact lens market, how illegally marketed devices are impacting industry, key ways to enhance sustainability, and much more.
Velomedix to expand therapeutic hypothermia system pilot study into Canada
Health Canada has approved Velomedix's pilot study of its rapid therapeutic hypothermia system, designed for use in patients with acute myocardial infarctions (AMIs or heart attacks).
Velico collaborates with Red Cross for spray-dried plasma development
Partially funded by the US and UK defence arms, FrontlineODP is designed to better allow the stockpiling of spray dried blood ahead of emergency or mass casualty events.
Velomedix enrols first patient in therapeutic hypothermia device trial
Velomedix has enrolled the first patient in a prospective, multi-centre clinical study of its rapid therapeutic hypothermia system for treating acute myocardial infarction (AMIs or heart attacks).
LimFlow begins enrolment for pDVA system study to treat CLI
French firm LimFlow has begun patient enrolment for a feasibility study of its Percutaneous Deep Vein Arterialisation (pDVA) system to treat patients with end-stage critical limb ischemia (CLI) in the US.
LimFlow to assess pDVA System in clinical study
Medical device firm LimFlow has received US Food and Drug Administration (FDA) approval for an investigational device exemption (IDE) pivotal study of its Percutaneous Deep Vein Arterialization (pDVA) System.
Medtronic completes patient enrollment for IN.PACT DEEP trial
Medtronic has completed enrolling patients in its IN.PACT DEEP trial, designed to demonstrate the safety and efficacy of Amphirion drug-eluting balloon in treating critical limb ischemia.
LimFlow reports positive data from LimFlow System trial
The findings showed that the LimFlow System achieved 66% amputation-free survival.
Philips’ endovascular system yields positive data in TOBA II BTK trial
The implantable device offers continued treatment effect and progressive impact on quality of life in PAD and CLI patients.
Cosense
Cosense, Inc. is an industry leader in the custom design and manufacture of non-invasive ultrasonic fluid detection sensors including air-in-line...
HAV device tested on the Ukraine frontlines
Humacyte present clinical results at the Military Health System Research Symposium of its Human Acellular Vessel device used in Ukraine.
The global challenge of stroke and pathways to better outcomes
One of the key challenges in stroke care is the limited window available for treatment once symptoms arise.
Concept Medical enrols first patient in balloon angioplasty trial
The announcement followed the company receiving Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA).
Extracorporeal organs could save the sickest patients from Covid-19
Extracorporeal membrane oxygenation (ECMO) does the job of the lungs and/or heart, allowing the organs to rest and recover when patients are incredibly sick. According to the Extracorporeal Life Support Organization (ELSO), the technique could save up to half of the seriously ill Covid-19 patients for whom ventilation isn’t working.
Under Pressure: Life-Saving Treatments for Complex Wounds
All wounds, whether brought on in combat or through disease, have time against them. Sarah Blackman discovers the latest techniques in healing complex wounds quickly and effectively.